|
|
Volumn 17 Suppl B, Issue , 2003, Pages
|
|
Is it time for quadruple therapy to be first line?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
ANTACID AGENT;
ANTIINFECTIVE AGENT;
BISMUTH;
CLARITHROMYCIN;
METRONIDAZOLE;
PROTON PUMP;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG COMBINATION;
DUODENUM ULCER;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
PEPTIC ULCER;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TIME;
AMOXICILLIN;
ANTACIDS;
ANTI-INFECTIVE AGENTS;
BISMUTH;
CLARITHROMYCIN;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
METRONIDAZOLE;
PEPTIC ULCER;
PROTON PUMPS;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
|
|
EID: 2142709639
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2003/303528 Document Type: Review |
|
Times cited : (8)
|
|
References (14)
|
